These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study). Mikhailidis DP; Wierzbicki AS Curr Med Res Opin; 2000; 16(3):205-7. PubMed ID: 11191011 [No Abstract] [Full Text] [Related]
6. Clinical inquiries. What is the target for low-density lipoprotein cholesterol in patients with heart disease? Stevermer JJ; Meadows SE J Fam Pract; 2002 Oct; 51(10):893. PubMed ID: 12401164 [No Abstract] [Full Text] [Related]
10. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease. Farnier M; Volpe M; Massaad R; Davies MJ; Allen C Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505 [TBL] [Abstract][Full Text] [Related]
11. [Ezetimib and simvastatin. Cooperation at receptors of cholesterol metabolism]. MMW Fortschr Med; 2005 Jul; 147(27-28):50. PubMed ID: 16041947 [No Abstract] [Full Text] [Related]
12. [On the current debate on lowering LDL cholesterol with ezetimibe]. Breuer HW Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008 [No Abstract] [Full Text] [Related]
13. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients. Averna M; Zaninelli A; Le Grazie C; Gensini GF J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660 [TBL] [Abstract][Full Text] [Related]
14. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study). Garmendia F; Brown AS; Reiber I; Adams PC Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012 [TBL] [Abstract][Full Text] [Related]
15. Treating hypercholesterolemia aggressively. Wilson CS Nebr Med J; 1996 Jan; 81(1):3-4. PubMed ID: 8584066 [No Abstract] [Full Text] [Related]
16. [The influence of ezetimibe and simvaststin on platelet aggregation and protein c system in patients with coronary heart disease and hypercholesterolemia]. Vashchenko VI; Kozobova AI; Filippov AE; Chechetkin AV; Popova NN; Vil'ianinov VN; Vashchenko TN Klin Med (Mosk); 2012; 90(3):66-8. PubMed ID: 22690571 [TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study. Ballantyne CM; Hoogeveen RC; Raya JL; Cain VA; Palmer MK; Karlson BW; Atherosclerosis; 2014 Jan; 232(1):86-93. PubMed ID: 24401221 [TBL] [Abstract][Full Text] [Related]
18. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia. Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197 [TBL] [Abstract][Full Text] [Related]
19. Prevention of coronary heart disease through cholesterol reduction. Grundy SM Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652 [TBL] [Abstract][Full Text] [Related]
20. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?]. Windler E Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000 [No Abstract] [Full Text] [Related] [Next] [New Search]